Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

77.03
-1.4900-1.90%
Volume:73.06K
Turnover:5.66M
Market Cap:6.01B
PE:77.81
High:78.42
Open:77.66
Low:76.81
Close:78.52
52wk High:82.94
52wk Low:35.20
Shares:78.02M
Float Shares:39.94M
Volume Ratio:0.56
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.19
PE(LYR):102.71

Loading ...

Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Notice Of Suspension

Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Correspondence

Form CORRESP - Correspondence
Jun 28, 2024

Notice Of Suspension

Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]
Jun 28, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments